Rapid Dose Therapeutics Corp.
DOSE
CNSX
| 11/30/2024 | 08/31/2024 | 05/31/2024 | 02/29/2024 | 11/30/2023 | |
|---|---|---|---|---|---|
| Net Income | -60.18% | -67.98% | -47.17% | -10.74% | 64.11% |
| Total Depreciation and Amortization | -50.17% | -32.17% | -16.09% | -3.10% | 5.95% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 589.58% | 357.04% | 181.69% | 9.74% | -94.27% |
| Change in Net Operating Assets | -75.91% | -94.52% | -91.83% | -67.97% | -22.09% |
| Cash from Operations | -126.85% | -439.07% | -268.01% | -158.00% | -19.10% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -94.35% | -37.16% | 136.52% | 171.25% | 184.86% |
| Total Debt Repaid | 73.26% | 50.06% | -348.36% | -366.63% | -579.24% |
| Issuance of Common Stock | 9,695.96% | 7,949.63% | 30,080.95% | 770.16% | -90.57% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -61.12% | -61.12% | -- | -- | 97.35% |
| Cash from Financing | 90.01% | 278.19% | 265.32% | 175.67% | 195.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | 100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -100.00% |
| Net Change in Cash | -187.48% | -168.78% | 193.81% | 1,778.33% | 248.87% |
